Entera Short Term Debt from 2010 to 2025

ENTX Stock  USD 2.34  0.11  4.93%   
Entera Bio Short Term Debt yearly trend continues to be fairly stable with very little volatility. Short Term Debt will likely drop to about 114.6 K in 2025. During the period from 2010 to 2025, Entera Bio Short Term Debt regression line of annual values had r-squared of  0.57 and arithmetic mean of  10,972,761. View All Fundamentals
 
Short Term Debt  
First Reported
2015-12-31
Previous Quarter
155 K
Current Value
162 K
Quarterly Volatility
11.9 M
 
Yuan Drop
 
Covid
Check Entera Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Entera Bio's main balance sheet or income statement drivers, such as Depreciation And Amortization of 97.3 K, Interest Expense of 31.4 M or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 79.86, Dividend Yield of 0.0 or PTB Ratio of 1.58. Entera financial statements analysis is a perfect complement when working with Entera Bio Valuation or Volatility modules.
  
Check out the analysis of Entera Bio Correlation against competitors.
For more information on how to buy Entera Stock please use our How to Invest in Entera Bio guide.

Latest Entera Bio's Short Term Debt Growth Pattern

Below is the plot of the Short Term Debt of Entera Bio over the last few years. It is Entera Bio's Short Term Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Entera Bio's overall financial position and show how it may be relating to other accounts over time.
Short Term Debt10 Years Trend
Slightly volatile
   Short Term Debt   
       Timeline  

Entera Short Term Debt Regression Statistics

Arithmetic Mean10,972,761
Geometric Mean1,958,198
Coefficient Of Variation111.41
Mean Deviation10,903,584
Median9,885,000
Standard Deviation12,224,660
Sample Variance149.4T
Range37.2M
R-Value(0.76)
Mean Square Error68.3T
R-Squared0.57
Significance0.0007
Slope(1,944,707)
Total Sum of Squares2241.6T

Entera Short Term Debt History

2025114.6 K
2024120.6 K
2023134 K
2022182 K
2021358 K
2020378 K

About Entera Bio Financial Statements

Entera Bio investors use historical fundamental indicators, such as Entera Bio's Short Term Debt, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Entera Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Short Term Debt120.6 K114.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Entera Stock Analysis

When running Entera Bio's price analysis, check to measure Entera Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Entera Bio is operating at the current time. Most of Entera Bio's value examination focuses on studying past and present price action to predict the probability of Entera Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Entera Bio's price. Additionally, you may evaluate how the addition of Entera Bio to your portfolios can decrease your overall portfolio volatility.